18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
about
Modern brain tumor imagingBiopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.Progress on the diagnosis and evaluation of brain tumors.Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.Non-invasive metabolic imaging of brain tumours in the era of precision medicine.PET/CT in Oncology: Current Status and Perspectives.Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapyEvaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients.Pseudoprogression after glioma therapy: a comprehensive review.Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab.The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.Lhermitte-Duclos disease presenting with positron emission tomography-magnetic resonance fusion imaging: a case report.Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma.18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.Persistent diffusion-restricted lesions in bevacizumab-treated malignant gliomas are associated with improved survival compared with matched controls.Correlation of MRI-derived apparent diffusion coefficients in newly diagnosed gliomas with [18F]-fluoro-L-dopa PET: what are we really measuring with minimum ADC?Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics-Relevance to Glioma.18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study.
P2860
Q27002344-E08A16DD-4997-4765-B645-7B1CE3469BB3Q30596682-DE647A16-69AE-4DF1-A006-AA285AB0ACEBQ30714285-6F765A5E-825E-4F39-9F27-1E29D09A54ACQ30907831-CD611DBF-E444-402E-AAF6-05D84CC3C92FQ31115540-614C4E5E-07BC-4270-A35A-A3BA0D5D1CF1Q33665109-B1AF05A5-1971-4193-B745-4850DFBECFE1Q33838502-4ECA6CBE-CBA0-49AE-BB25-F793F7A8ED7EQ33894461-5F056CC1-5636-4D2E-AABF-66E2DF3BEBF4Q34348544-7BAD14F3-CFAA-4B65-9676-4A2EBA8AA3F4Q36250739-505C258D-A12B-4818-A8E7-85C440B41D1BQ37641220-AA3BCA9C-A943-43A4-84AE-3BA6214463D2Q38094809-AD92FAB4-F894-43C9-82A6-AC576EC45825Q38815396-E00BBF16-497C-414D-BBDF-17005C5F6864Q41877778-5B6698D6-E3C8-4D9C-88BC-6032FBC9953AQ41900708-B85BAE84-E994-4B4C-BD7D-F3C2BFCD00F3Q42160028-79677583-3795-4F9D-976B-0AD31DED486EQ45267961-B5177D92-157E-4A0F-B491-EE18EA874088Q46366163-6144B497-084C-4E12-B05D-C33EB6E673AAQ46524386-48DAAA30-74A7-4A74-9C2A-EF9B95B398E7Q48330252-68B6B0FA-4792-4C8C-8698-5802AFC01BEBQ49829513-51A2EC6A-C5FA-444D-B27D-C303C8E97DA1Q54135407-F3366AC3-58C9-421C-8E54-CC2AACD61703
P2860
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
@en
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
@nl
type
label
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
@en
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
@nl
prefLabel
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
@en
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
@nl
P2093
P1476
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
@en
P2093
Bonnie Freitas
Carlos J Ledezma
Johannes Czernin
Tim Cloughesy
Victor Sai
Whitney Pope
P304
P356
10.1016/J.EJRAD.2008.04.018
P577
2008-05-29T00:00:00Z